While an essential role for mTOR in the regulation of liver metabolism is now widely recognized, our understanding of the upstream signals modulating this pathway and of their involvement in the pathogeneses of the metabolic syndrome and NAFLD remains incomplete (Bar‐Tana, 2020; Lamming & Sabatini, 2013). This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.